← Dashboard
Nov 06, 2026 09:57 AM ET
Signal
Corporate
Gyre Therapeutics GAAP EPS of -$0.04, revenue of $32.9M
Gyre Therapeutics reported GAAP EPS of -$0.04 and revenue of $32.9M.
What changed
Gyre Therapeutics reported GAAP EPS of -$0.04 and revenue of $32.9M.
Why it matters
Gyre Therapeutics reported GAAP EPS of -$0.04 and revenue of $32.9M. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
$FMX →